INmune Bio, Inc. (INMB)
1.78
+0.08
(+4.71%)
USD |
NASDAQ |
Dec 24, 12:59
1.82
+0.04
(+2.25%)
After-Hours: 13:59
INmune Bio Total Liabilities (Quarterly): 7.98M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
| Oragenics, Inc. | 2.874M |
| NanoViricides, Inc. | 1.182M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.36M |
| Shareholders Equity (Quarterly) | 25.38M |
| Debt to Equity Ratio | 0.0426 |
| Current Ratio | 4.169 |
| Net Debt Paydown Yield | 1.58% |